BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32620742)

  • 1. Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target.
    Franses JW; Philipp J; Missios P; Bhan I; Liu A; Yashaswini C; Tai E; Zhu H; Ligorio M; Nicholson B; Tassoni EM; Desai N; Kulkarni AS; Szabolcs A; Hong TS; Liss AS; Fernandez-Del Castillo C; Ryan DP; Maheswaran S; Haber DA; Daley GQ; Ting DT
    Nat Commun; 2020 Jul; 11(1):3303. PubMed ID: 32620742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT.
    Ma C; Nong K; Zhu H; Wang W; Huang X; Yuan Z; Ai K
    Tumour Biol; 2014 Sep; 35(9):9163-9. PubMed ID: 24920070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling.
    Yin J; Kim TH; Park N; Shin D; Choi HI; Cho S; Park JB; Kim JH
    Oncotarget; 2016 Nov; 7(48):79854-79868. PubMed ID: 27821801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis.
    Kadera BE; Li L; Toste PA; Wu N; Adams C; Dawson DW; Donahue TR
    PLoS One; 2013; 8(8):e71978. PubMed ID: 23991015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncogenic triangle of HMGA2, LIN28B and IGF2BP1 antagonizes tumor-suppressive actions of the let-7 family.
    Busch B; Bley N; Müller S; Glaß M; Misiak D; Lederer M; Vetter M; Strauß HG; Thomssen C; Hüttelmaier S
    Nucleic Acids Res; 2016 May; 44(8):3845-64. PubMed ID: 26917013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC.
    Alam M; Ahmad R; Rajabi H; Kufe D
    Mol Cancer Res; 2015 Mar; 13(3):449-60. PubMed ID: 25368430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression.
    Ottaviani S; Stebbing J; Frampton AE; Zagorac S; Krell J; de Giorgio A; Trabulo SM; Nguyen VTM; Magnani L; Feng H; Giovannetti E; Funel N; Gress TM; Jiao LR; Lombardo Y; Lemoine NR; Heeschen C; Castellano L
    Nat Commun; 2018 May; 9(1):1845. PubMed ID: 29748571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoplastic Transformation of Human Mesenchymal Stromal Cells Mediated via LIN28B.
    Vishnubalaji R; Elango R; Al-Toub M; Manikandan M; Al-Rikabi A; Harkness L; Ditzel N; Atteya M; Hamam R; Alfayez M; Aldahmash A; Kassem M; Alajez NM
    Sci Rep; 2019 May; 9(1):8101. PubMed ID: 31147574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LIN28B promotes the development of neuroendocrine prostate cancer.
    Lovnicki J; Gan Y; Feng T; Li Y; Xie N; Ho CH; Lee AR; Chen X; Nappi L; Han B; Fazli L; Huang J; Gleave ME; Dong X
    J Clin Invest; 2020 Oct; 130(10):5338-5348. PubMed ID: 32634132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b.
    Kugel S; Sebastián C; Fitamant J; Ross KN; Saha SK; Jain E; Gladden A; Arora KS; Kato Y; Rivera MN; Ramaswamy S; Sadreyev RI; Goren A; Deshpande V; Bardeesy N; Mostoslavsky R
    Cell; 2016 Jun; 165(6):1401-1415. PubMed ID: 27180906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance.
    Chiou SH; Dorsch M; Kusch E; Naranjo S; Kozak MM; Koong AC; Winslow MM; Grüner BM
    Sci Rep; 2018 Sep; 8(1):14008. PubMed ID: 30228296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2.
    Madison BB; Jeganathan AN; Mizuno R; Winslow MM; Castells A; Cuatrecasas M; Rustgi AK
    PLoS Genet; 2015 Aug; 11(8):e1005408. PubMed ID: 26244988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells.
    Dimitrov-Markov S; Perales-Patón J; Bockorny B; Dopazo A; Muñoz M; Baños N; Bonilla V; Menendez C; Duran Y; Huang L; Perea S; Muthuswamy SK; Al-Shahrour F; Lopez-Casas PP; Hidalgo M
    Mol Cancer Ther; 2020 Aug; 19(8):1751-1760. PubMed ID: 32499301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway.
    Alajez NM; Shi W; Wong D; Lenarduzzi M; Waldron J; Weinreb I; Liu FF
    Oncotarget; 2012 Dec; 3(12):1641-52. PubMed ID: 23482325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.
    Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S
    Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells.
    Li L; Li Z; Kong X; Xie D; Jia Z; Jiang W; Cui J; Du Y; Wei D; Huang S; Xie K
    Gastroenterology; 2014 Aug; 147(2):485-97.e18. PubMed ID: 24859161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition.
    Oliveira-Mateos C; Sánchez-Castillo A; Soler M; Obiols-Guardia A; Piñeyro D; Boque-Sastre R; Calleja-Cervantes ME; Castro de Moura M; Martínez-Cardús A; Rubio T; Pelletier J; Martínez-Iniesta M; Herrero-Martín D; Tirado OM; Gentilella A; Villanueva A; Esteller M; Farré L; Guil S
    Nat Commun; 2019 Sep; 10(1):3979. PubMed ID: 31484926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.
    Hsieh CC; Shyr YM; Liao WY; Chen TH; Wang SE; Lu PC; Lin PY; Chen YB; Mao WY; Han HY; Hsiao M; Yang WB; Li WS; Sher YP; Shen CN
    Oncotarget; 2017 Jan; 8(5):7691-7709. PubMed ID: 28032597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients.
    Sun Y; Wu G; Cheng KS; Chen A; Neoh KH; Chen S; Tang Z; Lee PF; Dai M; Han RPS
    EBioMedicine; 2019 Aug; 46():133-149. PubMed ID: 31375425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.